Degrees:
2011
Doctorate Medical and Health Sciences incl Neurosciences
Cancer Biology, Cancer Chemoresistance, Cancer Signaling, tumor vascularisation
Publications resulting from Research
1. Park Myo-Hyeon, Kim Ae Kyung, Manandhar Sarala, Oh Su-Young, Jang Gun-Hyuk, Li Kang, Hyeon Do Young, Lee Sun-Hee, Yoon Soo-Hyun, Lee Hye Eun, Lee SeHyung, Hwang Daehee, Byun Kyunghee and Lee You Mie. CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity. Elife. 2019 Aug 20;8. pii: e46012. doi: 10.7554/eLife.46012.
2. Manandhar Sarala and Lee You Mie. Emerging role of RUNX3 in the regulation of tumor Microenvironment. BMB Rep. 2018, 51(4): 174–181.
3. Manandhar Sarala, Kim Chang-gu, Lee Sun-Hee, Kang Soo Hyun, Basnet Nikita, and Lee You Mie. Exostosin 1 regulates cancer cell stemness in doxorubicin resistant breast cancer cells. Oncotarget. 2017, 3: 8(41):70521-7053. 4. Lee Sun Hee, Manandhar Sarala, and Lee You Mie. Role of RUNX in hypoxiainduced responses and angiogenesis. In: Ito, Y eds. Diverse Roles of RUNX Proteins in Development and Cancer. Adv Exp Med Biol. 2017: 962:449-469.(Equal contribution)
5. Manandhar Sarala, Choi Bo-hyun, Jung Kyeong-Ah, Ryoo In-geun, Song Mingu, Kang Su Jin, Choi Han-Gon, Kim Jung-Ae, Park Pil-Hoon and Kwak Mi- Kyoung. NRF2 inhibition represses ErbB2 signaling in ovarian carcinoma cells: Implications for tumor growth retardation and docetaxel sensitivity. Free Radic Biol Med. 2012, 52(9):1773-1785.
6. Manandhar Sarala, Lee Sangwhan, and Kwak Mi-Kyoung. Effect of Stable Inhibition of NRF2 on Doxorubicin Sensitivity in Human Ovarian Carcinoma OV90 Cells, Arch Pharm Res. 2010, 33(5):717-726. (Selected by Editors)
7. Shim Gi-seong, Manandhar Sarala, Shin Dong-ha, Kim Tae-Hyoung, Kwak MiKyoung. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway. Free Radic Biol Med. 2009, 47 (11):1619–1631. (Equal contribution)
8. Manandhar Sarala, You Aram, Lee Eung-Seok, Kim Jung-Ae, Kwak Mi- Kyoung, Activation of the Nrf2-antioxidant system by a novel cyclooxygenase-2 inhibitor furan2-yl-3-pyridin-2-yl-propenone: implication in anti-inflammatory function by Nrf2 activator, Journal of Pharmacy and Pharmacology, 2008, 60(7): 879-887.
9. Cho Jeong-Min, Manandhar Sarala, Lee Hyang Rim, Park Hyun Min, Kwak Mi- Kyoung. Role of the Nrf2 antioxidant system in cytotoxicity mediated by anticancer cisplatin: Implication to Cancer cell resistance; Cancer Lett. 2008, 260 (1-2): 96-108.
10. Manandhar Sarala, Cho Jeong-Min, Kim Jung- Ae, Kensler Thomas W, Kwak Mi- Kyoung. Induction of Nrf2- regulated genes by 3H-1,2- dithiole 3-thione through the ERK signaling pathway in Murine Keratinocyte, European Journal of Pharmacology. 2007, 577 (1-3): 17-27.
2. Manandhar Sarala and Lee You Mie. Emerging role of RUNX3 in the regulation of tumor Microenvironment. BMB Rep. 2018, 51(4): 174–181.
3. Manandhar Sarala, Kim Chang-gu, Lee Sun-Hee, Kang Soo Hyun, Basnet Nikita, and Lee You Mie. Exostosin 1 regulates cancer cell stemness in doxorubicin resistant breast cancer cells. Oncotarget. 2017, 3: 8(41):70521-7053. 4. Lee Sun Hee, Manandhar Sarala, and Lee You Mie. Role of RUNX in hypoxiainduced responses and angiogenesis. In: Ito, Y eds. Diverse Roles of RUNX Proteins in Development and Cancer. Adv Exp Med Biol. 2017: 962:449-469.(Equal contribution)
5. Manandhar Sarala, Choi Bo-hyun, Jung Kyeong-Ah, Ryoo In-geun, Song Mingu, Kang Su Jin, Choi Han-Gon, Kim Jung-Ae, Park Pil-Hoon and Kwak Mi- Kyoung. NRF2 inhibition represses ErbB2 signaling in ovarian carcinoma cells: Implications for tumor growth retardation and docetaxel sensitivity. Free Radic Biol Med. 2012, 52(9):1773-1785.
6. Manandhar Sarala, Lee Sangwhan, and Kwak Mi-Kyoung. Effect of Stable Inhibition of NRF2 on Doxorubicin Sensitivity in Human Ovarian Carcinoma OV90 Cells, Arch Pharm Res. 2010, 33(5):717-726. (Selected by Editors)
7. Shim Gi-seong, Manandhar Sarala, Shin Dong-ha, Kim Tae-Hyoung, Kwak MiKyoung. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway. Free Radic Biol Med. 2009, 47 (11):1619–1631. (Equal contribution)
8. Manandhar Sarala, You Aram, Lee Eung-Seok, Kim Jung-Ae, Kwak Mi- Kyoung, Activation of the Nrf2-antioxidant system by a novel cyclooxygenase-2 inhibitor furan2-yl-3-pyridin-2-yl-propenone: implication in anti-inflammatory function by Nrf2 activator, Journal of Pharmacy and Pharmacology, 2008, 60(7): 879-887.
9. Cho Jeong-Min, Manandhar Sarala, Lee Hyang Rim, Park Hyun Min, Kwak Mi- Kyoung. Role of the Nrf2 antioxidant system in cytotoxicity mediated by anticancer cisplatin: Implication to Cancer cell resistance; Cancer Lett. 2008, 260 (1-2): 96-108.
10. Manandhar Sarala, Cho Jeong-Min, Kim Jung- Ae, Kensler Thomas W, Kwak Mi- Kyoung. Induction of Nrf2- regulated genes by 3H-1,2- dithiole 3-thione through the ERK signaling pathway in Murine Keratinocyte, European Journal of Pharmacology. 2007, 577 (1-3): 17-27.
7 Lakes Proteoglycans conference
2025
American Association of Cancer Research (AACR)
2025
Matrix Biology Symposium
2025
American Association of Cancer Research (AACR)
2025
3rd International Conference on Bioscience and Biotechnology
2025
The Pharmaceutical Society of Korea
2025
Japan-Korea Joint Symposium of Vascular Biology
2025